Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
8.27
-0.05
(-0.66%)
At close: February 28 at 9:52:04 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
777,052
781,426
751,448
618,034
500,924
Cost of Revenue
670,601
606,375
577,383
466,491
375,181
Gross Profit
106,451
175,051
174,065
151,543
125,743
Operating Expense
205,170
217,548
153,215
109,864
73,943
Operating Income
-98,719
-42,497
20,850
41,679
51,800
Net Non Operating Interest Income Expense
-6,558
-2,476
-4,814
-6,982
-7,126
Other Income Expense
-96,860
-35,620
-169,992
202,283
-18,834
Pretax Income
-202,136
-80,593
-153,957
236,980
25,840
Tax Provision
-30,767
3,320
21,698
21,470
19,562
Net Income Common Stockholders
-171,370
-83,913
-175,655
215,510
6,278
Diluted NI Available to Com Stockholders
-171,370
-83,913
-175,655
215,510
6,278
Basic EPS
-0.97
-0.47
-0.99
1.30
0.04
Diluted EPS
-0.97
-0.47
-0.99
1.30
0.04
Basic Average Shares
177,192.28
176,916.66
176,674.34
166,405.93
153,752.24
Diluted Average Shares
177,553.38
176,916.66
176,674.34
166,405.93
153,752.24
Total Operating Income as Reported
-160,853
-47,507
20,850
40,996
48,556
Total Expenses
875,771
823,923
730,598
576,355
449,124
Net Income from Continuing & Discontinued Operation
-171,370
-83,913
-175,655
215,510
6,278
Normalized Income
-90,189.81
-54,242.90
-20,658.35
38,630.79
12,334.40
Interest Income
3,905
9,263
8,336
2,272
1,339
Interest Expense
10,463
11,739
13,150
9,254
8,465
Net Interest Income
-6,558
-2,476
-4,814
-6,982
-7,126
EBIT
-191,673
-68,854
-140,807
246,234
34,305
EBITDA
-191,673
24,125
-57,611
316,633
90,363
Reconciled Cost of Revenue
670,601
606,375
577,383
466,491
375,181
Reconciled Depreciation
--
92,979
83,196
70,399
56,058
Net Income from Continuing Operation Net Minority Interest
-171,370
-83,913
-175,655
215,510
6,278
Total Unusual Items Excluding Goodwill
-95,755
-34,906
-182,349
194,501
-8,652
Total Unusual Items
-95,755
-34,906
-182,349
194,501
-8,652
Normalized EBITDA
-95,918
59,031
124,738
122,132
99,015
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14,574.81
-5,235.90
-27,352.35
17,621.79
-2,595.60
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TKD.SG Takeda Pharmaceutical Co Ltd
27.50
+1.55%
N4P.L N4 Pharma Plc
0.5250
0.00%
TKUN.TA Tikun Olam-Cannbit Pharmaceuticals Ltd
35.30
-6.12%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
0.00%
DAN0.F DanCann Pharma A/S
0.3660
+12.68%
SBX.DE SynBiotic SE
3.6500
+1.11%
INCR.TA InterCure Ltd.
560.00
-1.69%
DICOT.ST Dicot Pharma AB
0.2745
-4.85%
FFEA.F Faes Farma, S.A.
3.5250
-6.25%
MYCO.CN Mydecine Innovations Group Inc.
0.0050
0.00%